Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.35 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21671486 | 0.97 | ADORA2A (0.36) | ADORA2AADRA2CMAOBMETAP2MEN1 | |
| SCHEMBL13170676 | 0.97 | ADORA2A (0.36) | ADORA2AADRA2CMAOBMETAP2MEN1 | |
| SCHEMBL13170637 | 0.97 | ADORA2A (0.37) | ADORA2AADRA2CMAOBMETAP2MEN1 | |
| SCHEMBL21671238 | 0.95 | MCL1 (0.42) | ADORA2AADRA2CMAOBMETAP2MEN1 | |
| SCHEMBL13170674 | 0.94 | GABRA1 (0.36) | ADORA2AADRA2CMAOBMEN1KMT2A | |
| SCHEMBL13192112 | 0.93 | ADRA2C (0.37) | ADORA2AADRA2CMAOBMETAP2MEN1 | |
| SCHEMBL13170672 | 0.92 | ADRA2C (0.44) | ADORA2AADRA2CMAOBMEN1KMT2A | |
| SCHEMBL13170640 | 0.91 | ADRA2C (0.46) | ADORA2AADRA2CMAOBMEN1KMT2A | |
| SCHEMBL21643660 | 0.91 | PDK2 (0.36) | ADORA2AADRA2CMAOBMETAP2MEN1 | |
| SCHEMBL30170086 | 0.91 | PDK2 (0.36) | ADORA2AADRA2CMAOBMETAP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9512137-B2 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9512137-B2 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20120256172-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
| US-20120256172-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
| US-20100039027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2010-02-18 | — | — | US | disclosed |
| US-20100039027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2113954-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2009-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120256172-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLC25A11, SLCO4C1 | ADORA2A 3175/4885ADRA2C 3360/4885MAOB 1913/4885 |
| US-20100039027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | RUVBL2, KCNB2, KCNB1 | ADORA2A 1458/4885ADRA2C 1987/4885MAOB 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.